Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Hematología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
INTERVENTIONAL
Inicio: 11 de may de 2017
ID: NCT03029208
Completado
Fase 3
ClinicalTrials.gov
An Extension Study to Evaluate the Long-term Outcomes of Subjects Who Received Treatment for Retinopathy of Prematurity in Study 20090
INTERVENTIONAL
Inicio: 18 de mar de 2020
ID: NCT04015180
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (VAYHIT1)
INTERVENTIONAL
Inicio: 3 de feb de 2023
ID: NCT05653349
Terminado
ClinicalTrials.gov
A Multinational, Multi-center, Prospective Cohort Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV) Serotypes in Subjects With Hemophilia A
INTERVENTIONAL
Inicio: 14 de mar de 2023
ID: NCT05580692
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure
INTERVENTIONAL
Inicio: 10 de sept de 2013
ID: NCT01877915
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial of Multiple Sublingual 5-MeO-DMT Microdoses for Reducing Anxiety and/or Depression in Patients With Mild Cognitive Impairment.
INTERVENTIONAL
Inicio: 15 de dic de 2024
ID: NCT06812221
Desconocido
Fase 4
ClinicalTrials.gov
Effectiveness of Weekly and Daily Iron Supplementation for the Prevention of Iron-deficiency Anemia in Infants. Impact on Genomic Stability
INTERVENTIONAL
Inicio: 1 de ago de 2017
ID: NCT03359447
Completado
Fase 3
ClinicalTrials.gov
Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk
INTERVENTIONAL
Inicio: 7 de ene de 2014
ID: NCT02111564
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents
INTERVENTIONAL
Inicio: 28 de sept de 2016
ID: NCT02879305
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
INTERVENTIONAL
Inicio: 11 de abr de 2011
ID: NCT01327846
Completado
Fase 3
ClinicalTrials.gov
BAX 326 (Recombinant Factor IX): A Phase 3 Prospective, Multicenter Study Evaluating Efficacy and Safety in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level 1-2%) Hemophilia B Undergoing Surgical or Other Invasive Procedures
INTERVENTIONAL
Inicio: 19 de dic de 2011
ID: NCT01507896
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy
INTERVENTIONAL
Inicio: 9 de jun de 2011
ID: NCT01311648
Reclutando
ClinicalTrials.gov
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
OBSERVATIONAL
Inicio: 1 de jul de 2022
ID: NCT05646394
Completado
Fase 3
ClinicalTrials.gov
A Phase II/III, Randomized, Cross-over, Open-label Trial to Demonstrate Superiority of Prophylaxis Over On-demand Therapy in Previously Treated Subjects With Severe Hemophilia A Treated With Plasma Protein-free Recombinant FVIII Formulated With Sucrose (BAY 81-8973)
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01233258
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
INTERVENTIONAL
Inicio: 21 de ago de 2018
ID: NCT03486873
Completado
Fase 3
ClinicalTrials.gov
A Two Part, Double-blind, Randomized, Placebo-controlled and Open-label Study to Investigate the Efficacy, Safety and Tolerability of Eltrombopag, a Thrombopoietin Receptor Agonist, in Pediatric Patients With Previously Treated Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP). PETIT2: Eltrombopag in PEdiatric Patients With Thrombocytopenia From ITP
INTERVENTIONAL
Inicio: 1 de mar de 2012
ID: NCT01520909
Completado
Fase 2
ClinicalTrials.gov
A Prospective, Randomized, Open Label, Multi-center Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist or LMWH in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention
INTERVENTIONAL
Inicio: 19 de ene de 2017
ID: NCT02981472
Por invitación
ClinicalTrials.gov
Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study
OBSERVATIONAL
Inicio: 1 de sept de 2024
ID: NCT07124377
Completado
Fase 4
ClinicalTrials.gov
Pilot Open Label Study to Evaluate Intravenous Ferric Carboxymaltose (Ferinject ®) in Patients With CKD (Pre-dialysis) With Anemia Treated With Epo and Oral Iron in Buenos Aires, Argentina
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT02232906
Completado
ClinicalTrials.gov
Prospective, Multinational, Non-interventional Post-authorisation Study to Document the Long-term Immunogenicity, Safety, and Efficacy of Human-cl rhFVIII (Simoctocog Alfa) in Patients With Haemophilia A Treated in Routine Clinical Practice
OBSERVATIONAL
Inicio: 1 de ene de 2015
ID: NCT02962765
Anterior
1
...
6
7
8
...
434
Siguiente
Filtros